Transcatheter-based aortic valve procedures have undergone a tremendous evolution and have led to great changes in the treatment of aortic valvular disease. In patients with severe peripheral arterial disease, transapical aortic valve implantation is an important alternative to surgical aortic valve replacement.
Patient had a history of coronary artery bypass grafting and chronic obstructive pulmonary disease.
Calculated Euroscore was 16.4% and due to the high surgical risk and presence of diffuse vascular disease, transapical aortic valve implantation was decided to be the optimal choice for the patient. However, severe stenosis of the infrarenal abdominal aorta and diffuse atherosclerotic iliac disease was seen on computed tomography angiography (Figure 1 ). Ascending aorta and arcus were also calcified preventing transaortic approach. TA-TAVI was decided to be the optimal choice for the patient.
The procedure was performed in the catheter laboratory under general anesthesia via a 5-6 cm anterolateral thoracotomy in the fifth intercostal space to access the apex of the heart. A bipolar epicardial pacing wire was placed and tested. Two purse stitches with Teflon felt pledgets using 3-0 decided to be more suitable. Although TAVI is the first alternative to SAVR in high-risk patients, TA-TAVI is a safe and effective option for those unsuitable for TAVI.
Conclusion
Transcatheter-based aortic valve procedures avoid the risks associated with open-heart surgery and therefore are generally indicated in patients with high surgical risk. Their main advantages are the avoidance of sternotomy and cardiopulmonary bypass along with the associated potential risks. Although TAVI is the first alternative to SAVR in high-risk patients, TA-TAVI is a safe and effective option for those unsuitable for TAVI.
